Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML
Thomas Oellerich(Goethe University Frankfurt), Jindřich Činátl(Goethe University Frankfurt)
Cited by 82
Related Papers
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia
|Cancer Cell|2017|116
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
|PLoS ONE|2021|96
An overview and a roadmap for artificial intelligence in hematology and oncology
|Journal of Cancer Research and Clinical Oncology|2023|84